breast-neoplasms

Documents about breast-neoplasms

• Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China#807535ClinicalTrials.gov
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer#888671ClinicalTrials.gov
• Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia#881219ClinicalTrials.gov
• Lymphaticovenous Anastomosis as Treatment for Lymphedema#847572ClinicalTrials.gov
• PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors#895346ClinicalTrials.gov
• Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer#811126ClinicalTrials.gov
• Persistent Pain After Breast Cancer Treatment With Docetaxel#847817ClinicalTrials.gov
• A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia#911244ClinicalTrials.gov
• The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer#410147Scholar Commons
• Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)#979539ClinicalTrials.gov
• Reversing Therapy Resistance With Epigenetic-Immune Modification#154645ClinicalTrials.gov
• DIEP Flap Surgery and Intraabdominal Pressure#907413ClinicalTrials.gov
• Prognostic disclosure in metastatic breast cancer: a scoping review.#9559PubMed
• Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy#813788ClinicalTrials.gov
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer#844627ClinicalTrials.gov
• Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors#857775ClinicalTrials.gov
• EMG at Performing ULTN 1 in Breast Cancer Patients#862231ClinicalTrials.gov
• A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer#866460ClinicalTrials.gov
• Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer#879993ClinicalTrials.gov
• Optimizing Functional Recovery After Breast Cancer Treatment#880043ClinicalTrials.gov
• A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer#994569ClinicalTrials.gov
• A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer#853476ClinicalTrials.gov
• MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer#856762ClinicalTrials.gov
• A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer#837059ClinicalTrials.gov
• FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.#881360ClinicalTrials.gov
• Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer#825106ClinicalTrials.gov
• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer#481750ClinicalTrials.gov
• Breast Cancer and Exercise Trial in Alberta#855105ClinicalTrials.gov
• Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m#858679ClinicalTrials.gov
• Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer#890831ClinicalTrials.gov
• Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study#981832ClinicalTrials.gov
• Impact of Physical Exercise on Lymphedema Related to Breast Cancer: Assessment Using Thermography#992736ClinicalTrials.gov
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)#844803ClinicalTrials.gov
• Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer#885742ClinicalTrials.gov
• Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer#892052ClinicalTrials.gov
• Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis#811078ClinicalTrials.gov
• Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country#880581ClinicalTrials.gov
• Ultrasound Targeting for the Lumpectomy Cavity#811343ClinicalTrials.gov
• PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient#992714ClinicalTrials.gov
• Photobiomodulation for Breast Cancer Radiodermatitis#835451ClinicalTrials.gov
• Use of Compressed Sensing in Breast MRI#877466ClinicalTrials.gov
• A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients#891875ClinicalTrials.gov
• Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device#916233ClinicalTrials.gov
• Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer#994121ClinicalTrials.gov
• Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction#852707ClinicalTrials.gov
• Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression#125839ClinicalTrials.gov
• TR(ACE) Assay Clinical Specimen Study#800548ClinicalTrials.gov
• Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium#812618ClinicalTrials.gov
• Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)#847477ClinicalTrials.gov
• DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast#858251ClinicalTrials.gov